| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 68672-66-2 | (Z)-2-(2-三苯甲基氨基噻唑-4-基)-2-(2-叔丁氧羰基丙-2-氧亞氨)乙酸 | (Z)-2-(2-Tritylaminothiazol-4-yl)-2-(2-tert-butoxycarbonylprop-2-oxyimino)acetic acid; (Z)-2-(tert-Butoxycarbonylprop-2-oxyimino)-2-(2-tritylaminothiazol-4-yl)acetic acid |  | C32H33N3O5S | 詳情 | 供應商 |
| 121058-82-0 | 5'-O-(4,4'-二甲氧基三苯甲基)-N4-乙�；�-2'-脫氧胞苷 | 5'-O-(4,4'-Dimethoxytrityl)-N4-acetyl-2'-deoxycytidine; N4-ACETYL-5'-(DIMETHOXYTRITYL)-2'-DEOXYCYTIDINE; N-ACETYL-5'-DMT DEOXYCYTIDINE; DMT-NAC-DC; 5'-O-(4,4'-DIMETHOXYTRITYL)-N4-ACETYL-2'-DEOXYCYTIDINE |  | C32H33N3O7 | 詳情 | 供應商 |
| 142217-77-4 | (1S,2S,3S,5S)-5-(2-氨基-6-芐氧基-9H-嘌呤-9-基)-3-芐氧基-2-芐氧基甲基環(huán)戊醇 | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopent; Cyclopentanol,5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,[1S-(1a,2b,3a,5b)]- (9CI); |  | C32H33N5O4 | 詳情 | 供應商 |
| 98056-69-0 | Adenosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-methyl- (9CI); 5’-O-(DIMETHOXYTRITYL)-N6-METHYL-2’-DEOXYADENOSINE; N6-ME-DMT-DEOXYADENOSINE |  | C32H33N5O5 | 詳情 | 供應商 | |
| 100898-63-3 | Cytidine,N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy- (9CI); DMT-NAC-DC; 5’-O-(4,4’-DIMETHOXYTRITYL)-N4-ACETYL-2’-DEOXYCYTIDINE; N4-ACETYL-5’-(DIMETHOXYTRITYL)-2’-DEOXYCYTIDINE; N-ACETYL-5’-DMT DEOXYCYTIDINE; N4-Acetyl-2’-deoxy-5’-O-DMT-D-cytidine; N4-Acetyl-5’’-O-(4,4’’-dimethoxytrityl)-2’’-deoxycytidine; 5’’-O-(4,4’’-Dimethoxytrityl)-N4-acetyl-2’’-deoxycytidine (synthetic) |  | C32H33N3O7 | 詳情 | 供應商 | |
| 108068-98-0 | 蛋白激酶仰制劑KT5720 | KT5720; (9R,10S,12S)-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID, HEXYL ESTER; KT5720; PROTEIN KINASE INHIBITOR KT 5720; 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, hexyl ester, (9R,10S,12S)-; (9s,10s,12r)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1h-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid hexyl ester; (9R,10S,12S)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, hexyl ester; 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-I][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, hexyl ester, (9R,10R,12S)-rel-; Aids004395 |  | C32H33N3O5 | 詳情 | 供應商 |
| 548783-71-7 | FEXOFENADINE-D6 |  | C32H33D6NO4 | 詳情 | 供應商 | |
| 180083-23-2 | 1'-METHYL-5-[[2'-METHYL-4'-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BIPHENYL-4-YL]CARBONYL]-2,3,6,7-TETRAHYDRO; 1'-METHYL-5-[[2'-METHYL-4'-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BIPHENYL-4-YL]CARBONYL]-2,3,6,7-TETRAHYDROSPIRO[FURO[2,3-F]INDOLE]-3,4'-PIPERIDINE HYDROCHLORIDE; 6,7-DIHYDRO-1'-METHYL-5-[[2'-METHYL-4'-(5-METHYL-1,2,4-OXADIAZOL-3-YL)[1,1'-BIPHENYL]-4-YL]CARBONYL]-SPIRO[2H-FURO[2,3-F]INDOLE-3(5H) HYDROCHLORIDE; SB 224,289 HYDROCHLORIDE; 1Methyl-5-((2methyl-4(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)carbonyl)-2,3,6,7-tetrahydrospiro(furo[2.3-f]ind; SB224289HCl |  | C32H33ClN4O3 | 詳情 | 供應商 | |
| 223595-20-8 | 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindo; 2,3-Dihydro-(1R)-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole; (1R)-2,3-Dihydro-1-methyl-5-(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)-2-(triphenylmethyl)-1H-isoindole; (R)-5-(1,3,6,2-Dioxazaborocan-2-yl)-1-methyl-2-tritylisoindoline; 2-((1R)-1-Methyl-2-trityl-2,3-dihydro-1H-isoindol-5-yl)-1,3,6,2-dioxazaborocane |  | C32H33BN2O2 | 詳情 | 供應商 |